Sirt1 overexpression in the nucleus and Sirt3 overexpression in the mitochondria have been demonstrated to improve antioxidant defense enzymes and decrease proinflammatory pathways [165], providing protection against NAFLD and acting as sensors to promote PGC-1α expression. This evidence concerns the gene SIRT3 and metabolic dysfunction-associated steatotic liver disease.